|
AU2008201350A1
|
|
Microdose therapy
|
|
AU2007231619A1
|
|
Compounds and methods for the treatment of urogenital disorders
|
|
JP2007056042A
|
|
Composition and method for treatment of anorectal disorder
|
|
AU2005244522A1
|
|
Microdose therapy
|
|
AU2003213787A1
|
|
Compositions and methods for the treatment of anorectal disorders
|
|
AU2002311264B2
|
|
Microdose therapy
|
|
AU2002340120A1
|
|
Semisolid topical hormonal compositions and methods for treatment
|
|
US2003222105A1
|
|
Taper well meter dose pump
|
|
CA2445712A1
|
|
Store operated calcium influx inhibitors and methods of use
|
|
US2002182260A1
|
|
Anti-inflammatory agents and methods for their preparation and use
|
|
WO02069906A2
|
|
Compounds and methods for the treatment of urogenital disorders
|
|
AU1884102A
|
|
Compositions and methods for the treatment of anorectal disorders
|
|
IL154202D0
|
|
Pharmaceutical compositions for treating anorectal disorders
|
|
US6627632B2
|
|
Compositions and methods for the treatment of anorectal disorders
|
|
ZA200104778B
|
|
Compositions and methods for the treatment of anorectal disorders.
|
|
EP1502604A1
|
|
Use of nitric oxide mimetics in cancer treatment
|
|
AU5537601A
|
|
Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
|
|
WO0143735A1
|
|
Nitroglycerin ointment for treatment of pain associated with anal disease
|
|
US6391869B1
|
|
Compositions and methods for the treatment of anorectal disorders
|
|
IL143726D0
|
|
A pharmaceutical composition containing a nitric oxide donor
|
